SEC Form D · Amendment · filed June 23, 2020
Olema Pharmaceuticals, Inc
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Andrew Rappaport · San Francisco, CADirectorCyrus Harmon · San Francisco, CAExec · DirectorFrank Mccormick · San Francisco, CADirectorGraham Walmsley · San Francisco, CADirectorGorjan Hrustanovic · San Francisco, CADirectorSamuel B. Carr, Jr · ST. PAUL, MNDirectorCourtland B. Cunningham · ST. PAUL, MNExec · DirectorCatherine L. Weyerhaeuser · ST. PAUL, MNDirectorDerek A. Mcdowell · Miami, FLDirectorCrossHarbor Institutional Partners 2021 GP, L.P · Boston, MADirectorPamela Klein · San Francisco, CAExecPeter Kushner · San Francisco, CAExecGlen T. Kacher · Palo Alto, CAExec · DirectorRobert M. Wenzell · Palo Alto, CADirectorAdam M. Hutt · New York, NYDirectorAMH Equity Ltd · New York, NYDirectorRachael Holladay · Austin, TXDirectorPamela Klein · San Francisco, CAExecPeter Kushner · San Francisco, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗